Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LFWD Lifeward	$0.62	$0.75	$0.50 ▼ $4.00	$9.66M	0.09	266,489 shs	341,205 shs
SSKN Strata Skin Sciences	$1.77 +1.1%	$2.12	$1.67 ▼ $3.79	$7.30M	0.66	14,999 shs	18,214 shs
STSS Sharps Technology	$7.36 +16.5%	$5.56	$3.36 ▼ $2,145.00	$7.53M	2.15	81,714 shs	204,732 shs
USAQ QHSLab	$0.19	$0.20	$0.08 ▼ $0.47	$2.01M	0.48	2,984 shs	N/A

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LFWD Lifeward	0.00%	-2.78%	-25.60%	-51.19%	-83.33%
SSKN Strata Skin Sciences	0.00%	-3.80%	-12.38%	-31.66%	-35.16%
STSS Sharps Technology	0.00%	+48.09%	+19.48%	+81.73%	+735,999,900.00%
USAQ QHSLab	0.00%	+0.53%	+5.56%	-25.58%	+27.09%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LFWD Lifeward	2.6467 of 5 stars	3.5	4.0	1.4	0.0	1.3
SSKN Strata Skin Sciences	2.5832 of 5 stars	3.5	3.0	1.8	1.7	0.6
STSS Sharps Technology	1.7025 of 5 stars	0.0	5.0	2.8	1.7	0.6
USAQ QHSLab	0.7272 of 5 stars	0.0	3.0	2.8	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LFWD Lifeward	3.00	Buy	$9.00	1,363.41% Upside
SSKN Strata Skin Sciences	3.00	Buy	$6.00	238.98% Upside
STSS Sharps Technology	0.00	N/A	N/A	N/A
USAQ QHSLab	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LFWD Lifeward	$25.66M	0.38	N/A	N/A	$0.96 per share	0.64
SSKN Strata Skin Sciences	$32.85M	0.22	N/A	N/A	$0.07 per share	25.29
STSS Sharps Technology	$222.72K	33.81	N/A	N/A	$14.21 per share	0.52
USAQ QHSLab	$2.13M	0.94	N/A	N/A	($0.06) per share	-3.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LFWD Lifeward	-$28.94M	-$3.12	N/A	N/A	N/A	-121.80%	-137.91%	-90.28%	11/11/2025 (Estimated)
SSKN Strata Skin Sciences	-$10.09M	-$2.84	N/A	N/A	N/A	-35.13%	-266.94%	-32.66%	11/12/2025 (Estimated)
STSS Sharps Technology	-$9.30M	-$1,212.34	N/A	∞	N/A	N/A	-8.72%	-5.30%	N/A
USAQ QHSLab	-$260K	-$0.04	N/A	∞	N/A	-15.33%	N/A	-21.37%	N/A

Latest USAQ, STSS, SSKN, and LFWD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	LFWD Lifeward	-$0.25	-$0.58	-$0.33	-$0.58	$6.62 million	$5.72 million
8/13/2025	Q2 2025	SSKN Strata Skin Sciences	-$0.27	-$0.60	-$0.33	-$0.60	$8.56 million	$7.70 million
8/13/2025	Q2 2025	STSS Sharps Technology	-$0.94	$3.58	+$4.52	$3.58	$0.25 million	$0.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LFWD Lifeward	N/A	N/A	N/A	N/A	N/A
SSKN Strata Skin Sciences	N/A	N/A	N/A	N/A	N/A
STSS Sharps Technology	N/A	N/A	N/A	N/A	N/A
USAQ QHSLab	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LFWD Lifeward	N/A	2.00	1.43
SSKN Strata Skin Sciences	49.58	0.98	0.87
STSS Sharps Technology	N/A	4.35	3.67
USAQ QHSLab	N/A	0.16	0.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LFWD Lifeward	26.76%
SSKN Strata Skin Sciences	32.43%
STSS Sharps Technology	17.17%
USAQ QHSLab	N/A

Insider Ownership

Company	Insider Ownership
LFWD Lifeward	2.70%
SSKN Strata Skin Sciences	39.00%
STSS Sharps Technology	0.15%
USAQ QHSLab	74.19%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LFWD Lifeward	60	15.70 million	15.28 million	Optionable
SSKN Strata Skin Sciences	120	4.17 million	2.54 million	Not Optionable
STSS Sharps Technology	3	1.02 million	1.02 million	Not Optionable
USAQ QHSLab	5	10.59 million	2.73 million	Not Optionable

USAQ, STSS, SSKN, and LFWD Headlines

Recent News About These Companies

Short Interest in QHSLab, Inc. (OTCMKTS:USAQ) Expands By 45.5%

August 21 at 2:59 AM | americanbankingnews.com

QHSLab (OTCMKTS:USAQ) Trading Down 13.3% - What's Next?

August 13, 2025 | americanbankingnews.com

QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services

July 8, 2025 | globenewswire.com

QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency

June 3, 2025 | globenewswire.com

QHSLab Enters Advanced Talks for Debt Restructuring

May 16, 2025 | tipranks.com

QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth

May 16, 2025 | globenewswire.com

Investing in Smarter Healthcare: The New Era of AI-Driven Medicine

May 15, 2025 | theglobeandmail.com

QHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025

May 15, 2025 | globenewswire.com

USA Equities Engages Hayden IR for Investor Relations

February 26, 2025 | tipranks.com

QHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations Program

February 26, 2025 | globenewswire.com

QHSLab’s Record Revenue Growth and First Profitable Year

February 18, 2025 | tipranks.com

QHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial Results

February 18, 2025 | globenewswire.com

QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth

February 11, 2025 | globenewswire.com

USA Equities Highlights 2025 Corporate Presentation

January 21, 2025 | tipranks.com

USA Equities to Exhibit at Pri-Med South Conference

January 16, 2025 | tipranks.com

USA Equities Outlines Growth Strategy Amid Challenges

December 17, 2024 | markets.businessinsider.com

QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology

December 13, 2024 | globenewswire.com

QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024

November 25, 2024 | globenewswire.com

QHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy Diagnostics

November 14, 2024 | globenewswire.com

US election latest: Harris set to give first speech since Trump's election win

November 7, 2024 | news.sky.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

USAQ, STSS, SSKN, and LFWD Company Descriptions

Lifeward NASDAQ:LFWD

$0.62 0.00 (0.00%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$0.63 +0.02 (+2.44%)

As of 08/22/2025 07:57 PM Eastern

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Strata Skin Sciences NASDAQ:SSKN

$1.77 +0.02 (+1.14%)

Closing price 08/22/2025 03:17 PM Eastern

Extended Trading

$1.74 -0.03 (-1.69%)

As of 08/22/2025 07:53 PM Eastern

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Sharps Technology NASDAQ:STSS

$7.36 +1.04 (+16.46%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$7.22 -0.14 (-1.90%)

As of 08/22/2025 07:52 PM Eastern

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

QHSLab OTCMKTS:USAQ

$0.19 0.00 (0.00%)

As of 08/22/2025

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time